SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-24-000009
Filing Date
2024-02-26
Accepted
2024-02-26 08:04:28
Documents
16
Period of Report
2024-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krys-20240226.htm   iXBRL 8-K 36250
2 EX-99.1 krys12312023ex991pressrele.htm EX-99.1 128643
6 image_0a.jpg GRAPHIC 187260
  Complete submission text file 0001711279-24-000009.txt   557783

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20240226.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20240226_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20240226_pre.xml EX-101.PRE 13052
17 EXTRACTED XBRL INSTANCE DOCUMENT krys-20240226_htm.xml XML 2792
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 24673609
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)